Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2016 Earnings

4AugConfirmed

Q4 2015

Q1 2016

Q2 2016

Q3 2016

-4.27

-3.96

-3.65

-3.34

Details

Expected EPS

-3.9819375

Actual EPS

-3.3448275

Surprise EPS

0.64

Surprise Percent

+16%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -3.3448275 per share for Q3 2016.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.